Product analysis
ThyroVen combines iodine with a range of plant ingredients, but unspecified forms make the formula difficult to compare. Its serving cost is relatively high for the iodine and turmeric contributions.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality21
Most ingredient forms are unspecified, making their quality difficult to compare. Naming the maca and chlorella species does not resolve uncertainty about the remaining preparations.
Ingredient Transparency71
All listed ingredient amounts are disclosed. Most forms are unspecified, limiting comparisons between equal amounts from different products.
Value For Money23
The serving cost is relatively high when considered for iodine or turmeric. Value for the other assessed ingredients remains uncertain.
Customer Satisfaction71
Customer feedback indicates high satisfaction. The small review pool limits how broadly that experience can be applied.
Product Focus34
The broad mixture of iodine and plant ingredients has limited support for its stated purpose. The ingredient count alone does not establish additional benefit.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.19
- Customer rating
- 4.7 · 54 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Iodine | 300 mcg | |
Atlantic Kelp | 414 mg | |
Wild Bear Garlic | 135 mg | |
Maca (Lepidium meyenii) | 90 mg | |
Chlorella (Chlorella sorokiniana) | 54 mg | |
Fennel | 54 mg | |
organic Turkey Tails | 36 mg | |
Turmeric | 36 mg | |
Parsley | 9 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study.
- Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
- Health-Related Quality of Life in Differentiated Thyroid Cancer Survivors: A Cross-Sectional Study From Turkey.